SCHEDULE 13G 0001858209 XXXXXXXX LIVE Common stock, $0.0001 par value 01/30/2026 0001861657 Tharimmune, Inc. 432705309 34 Shrewsbury Ave. Suite 1C Red Bank NJ 07701 Rule 13d-1(c) LCV Fund III, L.P. b DE 0 3964759 0 3964759 3964759 N 9.99 PN As of the date hereof, the Reporting Person's beneficial ownership consists of: (i) 757,724 shares of Common Stock, and (ii) 3,207,035 shares of Common Stock issuable upon the exercise of warrants (the "Warrants") within the next sixty (60) days. The aggregate amount beneficially owned does not consist of 920,917 shares of Common Stock, issuable upon the exercise of the Warrants because the Warrants are subject to restrictions included in the Subscription Agreement between the Issuer and the Reporting Person, which include a 9.99% blocker. The percentage reported in Item 11 is based on 36,444,785 shares of common stock outstanding as reported in the Issuer's definitive proxy statement on Schedule 14A filed with the SEC on December 24, 2025. LCV Fund III GP, L.P. b DE 0 3964759 0 3964759 3956766 N 9.99 PN As of the date hereof, the Reporting Person's beneficial ownership consists of: (i) 757,724 shares of Common Stock, and (ii) 3,207,035 shares of Common Stock issuable upon the exercise of the Warrant within the next sixty (60) days. Does not consist of 920,917 shares of Common Stock, issuable upon the exercise of the Warrants because the Warrants are subject to restrictions included in the Subscription Agreement between the Issuer and the Reporting Person, which include a 9.99% blocker. The percentage reported in Item 11 is based on 36,444,785 shares of common stock outstanding as reported in the Issuer's definitive proxy statement on Schedule 14A filed with the SEC on December 24, 2025. LCV GP III, L.L.C. b DE 0 3964759 0 3964759 3964759 N 9.99 CO As of the date hereof, the Reporting Person's beneficial ownership consists of: (i) 757,724 shares of Common Stock, and (ii) 3,207,035 shares of Common Stock issuable upon the exercise of the Warrant within the next sixty (60) days. Does not consist of (i) 920,917 shares of Common Stock, issuable upon the exercise of the Warrants because the Warrants are subject to restrictions included in the Subscription Agreement between the Issuer and the Reporting Person, which include a 9.99% blocker. The percentage reported in Item 11 is based on 36,444,785 shares of common stock outstanding as reported in the Issuer's definitive proxy statement on Schedule 14A filed with the SEC on December 24, 2025. LCV Fund VIII, L.P. b DE 0 4044927 0 4044927 4044927 N 9.99 PN As of the date hereof, the Reporting Person's beneficial ownership consists of 4,044,927 shares of Common Stock issuable upon the exercise of the Warrants within the next sixty (60) days. Does not consist of 8,282,625 shares of Common Stock, issuable upon the exercise of the Warrants because the Warrants are subject to restrictions included in the Subscription Agreement between the Issuer and the Reporting Person, which include a 9.99% blocker. The percentage reported in Item 11 is based on 36,444,785 shares of common stock outstanding as reported in the Issuer's definitive proxy statement on Schedule 14A filed with the SEC on December 24, 2025. LCV GP VIII, L.L.C. b DE 0 4044927 0 4044927 4044927 N 9.99 CO As of the date hereof, the Reporting Person's beneficial ownership consists of 4,044,927 shares of Common Stock issuable upon the exercise of the Warrants within the next sixty (60) days. Does not consist of 8,282,625 shares of Common Stock, issuable upon the exercise of the Warrants because the Warrants are subject to restrictions included in the Subscription Agreement between the Issuer and the Reporting Person, which include a 9.99% blocker. The percentage reported in Item 11 is based on 36,444,785 shares of common stock outstanding as reported in the Issuer's definitive proxy statement on Schedule 14A filed with the SEC on December 24, 2025. LCV Blockchain Management, LLC b DE 0 3957086 0 3957086 3956086 N 9.98 CO As of the date hereof, the Reporting Person's beneficial ownership consists of: (i) 757,724 shares of Common Stock, and (ii) 3,199,362 shares of Common Stock issuable upon the exercise of the Warrant within the next sixty (60) days. Does not consist of 13,301,142 shares of Common Stock, issuable upon the exercise of the Warrants because the Warrants are subject to restrictions included in the Subscription Agreement between the Issuer and the Reporting Person, which include a 9.99% blocker. The percentage reported in Item 11 is based on 36,444,785 shares of common stock outstanding as reported in the Issuer's definitive proxy statement on Schedule 14A filed with the SEC on December 24, 2025. Murtaza S. Akbar b X1 0 3957086 0 3957086 3957086 N 9.98 IN As of the date hereof, the Reporting Person's beneficial ownership consists of: (i) 757,724 shares of Common Stock, and (ii) 3,199,362 shares of Common Stock issuable upon the exercise of the Warrant within the next sixty (60) days. Does not consist of 13,301,142 shares of Common Stock, issuable upon the exercise of the Warrants because the Warrants are subject to restrictions included in the Subscription Agreement between the Issuer and the Reporting Person, which include a 9.99% blocker. The percentage reported in Item 11 is based on 36,444,785 shares of common stock outstanding as reported in the Issuer's definitive proxy statement on Schedule 14A filed with the SEC on December 24, 2025. Emil Woods b X1 0 3957086 0 3957086 3957086 N 9.98 IN As of the date hereof, the Reporting Person's beneficial ownership consists of: (i) 757,724 shares of Common Stock, and (ii) 3,199,362 shares of Common Stock issuable upon the exercise of the Warrant within the next sixty (60) days. Does not consist of 13,301,142 shares of Common Stock, issuable upon the exercise of the Warrants because the Warrants are subject to restrictions included in the Subscription Agreement between the Issuer and the Reporting Person, which include a 9.99% blocker. The percentage reported in Item 11 is based on 36,444,785 shares of common stock outstanding as reported in the Issuer's definitive proxy statement on Schedule 14A filed with the SEC on December 24, 2025. Tharimmune, Inc. 34 Shrewsbury Ave., Suite 1C, Red Bank, NJ 07701 Each of the following is hereinafter individually referred to as a "Reporting Person" and collectively as the "Reporting Persons." This statement is filed on behalf of: i. LCV Fund III, L.P. ii. LCV Fund III GP, L.P. iii. LCV GP III, L.L.C. iv. LCV Fund VIII, L.P. v. LCV GP VIII, L.L.C. vi. LCV Blockchain Management, L.L.C. vii. Murtaza S. Akbar viii. Emil Woods LCV GP III, L.L.C. is the general partner of LCV Fund III GP, L.P., which is the general partner of LCV Fund III, L.P. and, as such, may be deemed to beneficially own the shares held by LCV Fund III, L.P. LCV GP VIII, L.L.C. is the general partner of LCV Fund VIII, L.P. and, as such, may be deemed to beneficially own the shares held by LCV Fund VIII, L.P. LCV GP III, L.L.C. and LCV GP VIII, L.L.C. are under common control by LCV Blockchain Management, L.L.C. and, as such, LCV Blockchain Management, L.L.C. may be deemed to beneficially own the shares held by LCV Fund III GP, L.P. and LCV Fund VIII, L.P. Murtaza S. Akbar and Emil Woods share voting and investment control of LCV Fund III, L.P. and LCV Fund VIII, L.P. (together, the "LCV Funds") through the general partner entities of the LCV Funds and may be deemed the beneficial owners of such shares. 120 East 16th Street, 12th floor, New York, NY 10003. See Item 4 of the cover page for each Reporting Person. Y See Items 5-11 of the cover page for each Reporting Person. See Items 5-11 of the cover page for each Reporting Person. As of the date hereof, each Reporting Person, considered together hold an aggregate of 16,500,504 warrants, which are exercisable into an aggregate of 16,500,504 shares of Common Stock. The warrants are exercisable at the discretion of the Reporting Person at any time at an exercise price of $0.0001 per Common Stock. A holder of warrants will not be entitled to exercise any portion of any Warrant held by them that, upon giving effect to such exercise, would cause the aggregate number of Common Stock beneficially owned by such holder to exceed 9.99% of the number of Common Stock that would be outstanding immediately after giving effect to the exercise. See Items 5-11 of the cover page for each Reporting Person. See Items 5-11 of the cover page for each Reporting Person. See Items 5-11 of the cover page for each Reporting Person. See Items 5-11 of the cover page for each Reporting Person. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. LCV Fund III, L.P. /s/ Brian Whitehurst 02/02/2026 LCV Fund III GP, L.P. /s/ Brian Whitehurst 02/02/2026 LCV GP III, L.L.C. /s/ Brian Whitehurst 02/02/2026 LCV Fund VIII, L.P. /s/ Brian Whitehurst 02/02/2026 LCV GP VIII, L.L.C. /s/ Brian Whitehurst 02/02/2026 LCV Blockchain Management, LLC /s/ Brian Whitehurst 02/02/2026 Murtaza S. Akbar /s/ Murtaza S. Akbar 02/02/2026 Emil Woods /s/ Emil Woods 02/02/2026